Determination of the fold-change in the ratio of CD109/β-actin in the limited SSc and diffuse SSc groups compared with normal controls shows that both limited SSc and diffuse SSc skin fibroblasts display significantly (P < 0.05) higher CD109 protein levels compared with normal skin fibroblasts (Figure 2C). The gene discussed is ACTB; the disease is systemic sclerosis.